CHO Pharma, Inc. (TPEX: 6586)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
51.40
+0.50 (0.98%)
Jan 21, 2025, 2:57 PM CST
-24.19%
Market Cap 11.00B
Revenue (ttm) 1.08M
Net Income (ttm) -255.25M
Shares Out 214.01M
EPS (ttm) -1.24
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 75,188
Average Volume 161,796
Open 50.90
Previous Close 50.90
Day's Range 50.60 - 52.20
52-Week Range 49.00 - 72.30
Beta 0.15
RSI 48.32
Earnings Date Mar 21, 2025

About CHO Pharma

CHO Pharma, Inc., a biopharmaceutical company, develops and commercializes therapeutic and diagnostic products for the unmet clinical needs. It is developing homogeneous antibody drugs, such as CHO-H01, CHO-H02, and CHO-A04, a humanized monoclonal antibody for cancer; CHO-H03, a homogeneous antibody drug for autoimmune diseases; CHO-S05 dual-effect anti-flu drugs; and CHO-V08 for Klebsiella pneumonia. The company was founded in 2012 and is based in Taipei City, Taiwan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2012
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 6586
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.